New hope for devastating breast cancer complication: targeting brain and spine spread
NCT ID NCT06016387
Summary
This study is testing whether a combination of targeted radiation to the brain and/or spine, followed by a three-drug therapy, is safe and effective for people with an aggressive form of advanced breast cancer that has spread to the fluid surrounding the brain and spinal cord. It will enroll about 30 adults with this specific cancer type to see if the treatment can help them live longer and control the disease in the nervous system. The goal is to find a better way to manage this very serious condition where current survival is often measured in just a few months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.